New ultrasound device aims to speed up dialysis access healing

NCT ID NCT06190717

Recruiting now Disease control Sponsor: Sonavex, Inc. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a device called EchoMark/EchoSure that is implanted during fistula surgery for dialysis patients. The device uses automated ultrasound to monitor healing every two weeks. The goal is to see if it helps the fistula mature faster and reduces the need for additional procedures. About 304 adults with kidney failure and diabetes are being enrolled.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: EchoMark/EchoSure device
What this could lead to: If successful, this device could help dialysis patients get their fistula ready for use faster, reducing the need for extra procedures.
What could go wrong: This is a relatively early-stage device trial with 304 participants. The device may not significantly speed up maturation, and there are risks like implant migration or infection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

chronic kidney disease diabetes mellitus end stage renal failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

DIABETES END-STAGE RENAL DISEASE

Contacts and locations

Locations

AKDHC Center Tucson
RECRUITING

Tucson, Arizona, 85754, United States
AKDHC Medical Research Services
RECRUITING

Phoenix, Arizona, 85012, United States
Aqua Research Institute Llc
RECRUITING

Houston, Texas, 77058, United States
Atrium Health
RECRUITING

Concord, North Carolina, 28025, United States
Baylor Scott & White Heart and Vascular Hospital
RECRUITING

Dallas, Texas, 75226, United States
Boston Medical Center
RECRUITING

Boston, Massachusetts, 02118, United States
Capital Medical Center
RECRUITING

Pennington, New Jersey, 08534, United States
Fresenius Vascular Care Memphis MSO
TERMINATED

Memphis, Tennessee, 38115, United States
Galen Medical Group
RECRUITING

Chattanooga, Tennessee, 37421, United States
HealthQare Associates
RECRUITING

Arlington, Virginia, 22201, United States
Kansas Nephrology Research Institute
RECRUITING

Wichita, Kansas, 67214, United States
MSU Health Care Heart and Vascular
RECRUITING

Lansing, Michigan, 48910, United States
Medical University of South Carolina Health Orangeburg
RECRUITING

Orangeburg, South Carolina, 29118, United States
Northwell Health
RECRUITING

New Hyde Park, New York, 11042, United States
Northwestern University
RECRUITING

Chicago, Illinois, 60611, United States
Orlando Health Heart and Vascular Institute
RECRUITING

Orlando, Florida, 32806, United States
Physicians Care of Virginia
RECRUITING

Roanoke, Virginia, 24014, United States
Prisma Health
RECRUITING

Greenville, South Carolina, 29605, United States
Sentara Health
RECRUITING

Virginia Beach, Virginia, 23454, United States
Southwest Kidney Institute
RECRUITING

Phoenix, Arizona, 85004, United States
Trinity Research Group
RECRUITING

Dothan, Alabama, 36301, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.